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Holins are integral membrane proteins that control the access of phage-encoded muralytic enzymes, or
endolysins, to the cell wall by the sudden formation of an uncharacterized homo-oligomeric lesion, or hole, in
the membrane, at a precisely defined time. The timing of l-infected cell lysis depends solely on the 107 codon
S gene, which encodes two proteins, S105 and S107, which are the holin and holin inhibitor, respectively. Here
we report the results of biochemical and genetic studies on the interaction between the holin and the holin
inhibitor. A unique cysteine at position 51, in the middle of the second transmembrane domain, is shown to
cause the formation of disulfide-linked dimers during detergent membrane extraction. Forced oxidation of
membranes containing S molecules also results in the formation of covalently linked dimers. This technique
is used to demonstrate efficient dimeric interactions between S105 and S107. These results, coupled with the
previous finding that the timing of lysis depends on the excess of the amount of S105 over S107, suggest a model
in which the inhibitor functions by titrating out the effector in a stoichiometric fashion. This provides a basis
for understanding two evolutionary advantages provided by the inhibitor system, in which the production of the
inhibitor not only causes a delay in the timing of lysis, allowing the assembly of more virions, but also increases
effective hole formation after triggering.
Bacteriophage l has four lysis genes S, R, Rz, and Rz1 (8, 19,
25, 26, 40). Only S and R are absolutely required for host cell
lysis under standard laboratory conditions (14, 15). Rz and Rz1
are required for lysis only when the outer membrane is stabi-
lized by millimolar concentrations of divalent cations (40, 42).
The overlapping lysis genes are clustered in a region referred
to as the lysis cassette, and are located downstream of the
single late gene promoter pR9 (Fig. 1A). The l R gene encodes
the endolysin, a soluble, cytoplasmic transglycosylase that ac-
cumulates throughout late gene expression (2, 8). The S gene,
or holin, is a 107 codon open reading frame that encodes two
nearly identical inner membrane proteins with opposing func-
tions (3, 5, 10). Holins are responsible for controlling endolysin
access to the host cell wall (38). At a precisely scheduled time
programmed into the structure of the holin the host cytoplas-
mic membrane is permeabilized, allowing the transglycosylase
access to the peptidoglycan, resulting in immediate cell lysis
(37–39). Four lines of evidence speak to the nature of the hole.
First, S acts independently of all other host and phage gene
products to effect lysis; thus, the holes are thought to be com-
posed solely of S protein (13, 30, 38). Second, cross-linking
experiments demonstrate that the l S protein can exist in an
oligomeric state in the inner membrane (41). Third, the lesion
has to be of sufficient size to allow the escape of fully folded
18-kDa endolysin in l-infected cells, as well as endolysins up to
70 kDa from other phage-infected cells (12, 20, 23). Fourth,
the hole is apparently nonspecific since permeabilization of the
membrane by l S allows the escape of heterologous endolysins
(7, 21, 34). However, the true nature of the holin-mediated
membrane lesion remains elusive.
Despite a lack of structural data with respect to the hole, the
understanding of holin regulation and function has continued
to advance. It is known that two distinct proteins, S107 and
S105, are expressed from the S gene and are composed of 107
and 105 amino acids, respectively (Fig. 1B and C). Although
these two proteins differ by only two N-terminal residues (the
N-terminal Met1-Lys2 extension of S107), they have opposing
functions. The shorter product, S105, is the actual lysis effector,
whereas the longer product, S107, functions as a specific in-
hibitor of S105 (3, 5, 24). Genetic studies revealed an mRNA
secondary structure near the 59 end of the S gene that controls
translational initiations from Met1 and Met3 (Fig. 1C). This
structure, termed sdi (for site-directed initiation), determines
the ratio of S105 to S107, which is approximately 2:1 (10). S107
has a dual capacity; it acts as an inhibitor as long as the
membrane is energized and actively contributes to hole forma-
tion upon depolarization of the membrane (3). Previous stud-
ies have shown that the additional positive charge at the N
terminus of S107 is required for this inhibitory function (3, 33).
Substitution of the lysine by the negatively charged residue
glutamate not only abolishes inhibition but converts S107 into
a lysis effector protein (3).
Recently, it has been shown that S has three membrane-
spanning domains with the N terminus located in the periplasm
and the C terminus located in the cytosol (9, 16, 17, 35) (Fig.
1D). Graschopf and Bla¨si have proposed a molecular basis for
the difference between S107 and S105 (16). These authors
reported that the extension of the N terminus of S105 with a
secretory signal sequence conferred leader peptidase depen-
dency on the holin, strongly suggesting that the translocation of
the N terminus to the periplasm is required for S function.
Moreover, these results also implied that the extra N-terminal
positive charge of S107 prevents or retards translocation of its
N terminus to the periplasm, as demonstrated for other N-
terminal translocation events in oligotopic membrane proteins
with the same topology (Fig. 1D) (16, 35). Accordingly, the
ability of S107 to inhibit S105 suggests that it interacts directly
* Corresponding author. Mailing address: Department of Biochem-
istry and Biophysics, Texas A&M University, College Station, TX 77843-
2128. Phone: (979) 845-2087. Fax: (979) 862-4718. E-mail: ryland
@tamu.edu.
6075
 o
n
 Septem
ber 21, 2018 by guest
http://jb.asm.org/
D
ow
nloaded from
 
with the holin effector and that its N-in topology poisons hole
formation, as previously proposed (6).
Here we report genetic, physiological and biochemical ex-
periments to characterize the interaction between the l S holin
and the holin inhibitor in the membrane. The results are dis-
cussed in terms of a model for the control of lysis timing and
the evolutionary advantages of the holin-endolysin pathway.
MATERIALS AND METHODS
Materials, strains, bacteriophages, plasmids, and growth media. N-Ethylma-
leimide (NEM) and 1-10 phenanthroline were purchased from Sigma-Aldrich
(St. Louis, Mo.). All other reagents were of the highest purity commercially
available. The strains MC4100, XL1-Blue, the lysis-defective thermoinducible
prophages lCmDSR and lKnDSR, and the lysis-proficient thermoinducible
prophages lCmS105 (expressing S105) and lCmS105t94 (expressing the histi-
dine-tagged S105t94) have been described previously (24, 28, 31). lCmS107 is
essentially the same as lCmS105 with the exception that this phage has the M3L
instead of the M1L mutation within the S gene and therefore expresses S107
protein only. Media, growth conditions, and thermal induction of the l lysis
genes from a prophage and/or plasmid have been described previously (10, 17,
30). The ability of S alleles to be triggered by cyanide was assessed by adding
KCN to a final concentration of 10 mM to a portion of an induced culture. A 1 M
KCN stock solution was freshly prepared just prior to use. All cells harboring a
plasmid were grown in Luria broth with 100 mg of ampicillin/ml. Cells harboring
a kanamycin- or chloramphenicol-resistant prophage were grown in LB with 40
mg of kanamycin or 10 mg of Cm chloramphicol per ml, respectively. Cells
containing both a chloramphenicol-resistant prophage and an Ap plasmid were
grown in LB-ampicillin medium without chloramphenicol.
Standard DNA manipulations, PCR, site-directed mutagenesis, and DNA
sequencing. Plasmids used in this study and plasmids newly constructed by site-
directed mutagenesis are listed in Table 1, along with the single base changes.
Site-directed mutagenesis was performed using the QuikChange kit from Strat-
agene (La Jolla, Calif.) as described previously (17). Base changes in all con-
structs were verified by automated fluorescence sequencing as described previ-
ously (29).
Protein sample preparation, SDS-PAGE, Western blotting, and immunode-
tection. Triton X-100-solubilized preparations of inner membrane proteins were
obtained as described previously (10, 29). Briefly, 5-ml aliquots of induced
cultures were disrupted by a single passage through a large SLM-Aminco French
pressure cell (Spectronic Instruments, Rochester, N.Y.) at 16,000 lb/in2. The
membrane fraction was collected from the disrupted sample by ultracentrifuga-
tion at 100,000 3 g for 60 min at 18°C. The membrane pellet was solubilized in
50 ml of membrane extraction buffer (1% Triton X-100, 10% glycerol, 0.5 M
NaCl, 35 mM MgCl2, 20 mM Tris-HCl, pH 8.0) for 12 to 14 h at 37°C. Where
indicated, the membrane extraction buffer was supplemented with 0.1 M NEM to
avoid formation of disulfide bridges. After solubilization of the membrane pellet,
detergent-insoluble material was removed by ultracentrifugation at 100,000 3 g
for 45 min at 18°C. Unless otherwise stated the detergent-soluble fraction was
diluted 1:1 with 23 protein sample buffer devoid of reducing agent prior to
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analy-
sis. Protein samples were placed for 10 min at 37°C and then centrifuged at
14,000 3 g for 5 min at room temperature. Proteins were separated on a precast
16% Tris-Tricine mini gel (Xcell II Minicell; Novex, San Diego, Calif.) following
the manufacturer’s instruction. Western blotting and immunodetection with
anti-S antibodies were performed as described previously (17).
FIG. 1. l lysis cassette, translational control region, primary structure, and putative membrane topology for l S. (A) All four lambda lysis genes—S, R, Rz, and
Rz1—lie in an overlapping cluster in the lysis cassette downstream of the single late gene promoter pR9. Expression of the lysis genes is dependent on the antiterminator
protein Q. (B) The primary structure of l S is shown. Charged residues are indicated by 1 or 2. Transmembrane domains as predicted by the TMHMM program are
indicated (555) below the sequence (http://www.cbs.dtu.dk/services/TMHMM-1.0/) (32). The highly charged dispensable C-terminal region is indicated by asterisks
(4), and the two start codons of S are indicated (#) below the sequence. The missense changes of two early lysis alleles are marked by arrows above the sequence. The
position and sequence of the oligo-histidine tag in St94H is also indicated above the sequence. (C) The dual-start motif of l S is shown. The boxed sequences indicate
the Shine-Dalgarno sequences for the dual translational starts of S. The length of both protein products is given in amino acid (aa) residues. (D) Topological model
for l S with three alpha-helical transmembrane domains (2). A putative intermediate membrane topology for the lysis inhibitor, S107 is also depicted (1).
TABLE 1. Plasmids used in this study
Plasmid Description Reference
pKB1 Derivative of pOR19; l lysis gene region
(Sam7) cloned as HindIII/ClaI fragment
(l nta 4141–46440)
22
pKB110 Derivative of pOR19; l lysis gene region
cloned as HindIII/ClaI fragment (l nt
4141–46440)
9
pS105 S with M1L mutation (ATG3CTG); bears
S105 only
30
pS107 S with M3L mutation (ATG3CTG); bears
S107 only
This study
pS105t94 Insertion (G2H6G2) after codon F94 in S105 30
pS105A52G S105 with A52G mutation (GCC3GGC) 31
pS105C51S S105 with C51S mutation (TGC3AGC) 17
pSC51S S with C51S mutation (TGC3AGC) This study
pSA52G S with A52G mutation (GCC3GGC) This study
pS107C51S S107 with C51S mutation (TGC3AGC) This study
pS107A52G S107 with A52G mutation (GCC3GGC) This study
a nt, nucleotides.
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Determination of protein synthesis, protein stability, and protein concen-
tration. To analyze levels of S synthesis as well as protein stability, MC4100
(lKnDSR) bearing the plasmids pS107 or pS107C51S was induced at an A550 of
0.2 as described above. Aliquots (5 ml) were withdrawn 30, 60, and 90 min after
thermal induction, and the Triton X-100 soluble fractions of inner membrane
proteins were prepared as described. Total protein concentrations of these ex-
tracts were measured using the DC protein assay from Bio-Rad (Hercules, Calif.)
following the manufacturer’s instructions. Protein samples were mixed 1:1 with
23 sample buffer containing 2.8 M b-mercaptoethanol, incubated 5 min at
100°C, and centrifuged at 14,000 3 g for 5 min at room temperature. Samples
were then analyzed by SDS-PAGE as described above.
Oxidative disulfide bridge formation in membranes. Cultures expressing one
or two S alleles from a prophage, plasmid, or both were induced as described
above, except that the cells were induced at an A550 of 0.3. Unless otherwise
stated, 5-ml aliquots were disrupted in a French pressure cell after cell lysis was
completed or 100 min after induction and oxidized with 20 mM CuSO4 and 60
mM 1-10 phenanthroline for 60 min at room temperature. The reactions were
stopped by the addition of 0.1 M NEM, and incubation was continued at room
temperature for an additional 60 min. A stock solution of CuSO4 was prepared
in double-distilled water, and stock solutions of 1-10 phenanthroline and NEM
were prepared in ethanol just prior to use. Membrane proteins were extracted in
the presence of 0.1 M NEM, and protein samples were prepared for SDS-PAGE
as described above. As a control to ensure that disulfide bond formation did not
occur during sample preparation, two different plasmid-borne S alleles were
induced in separate cultures and mixed shortly before disruption in the French
pressure cell. These combined lysates were then subjected to centrifugation and
detergent extraction as described above.
RESULTS
Cys51 supports oxidative dimerization of l S but is nones-
sential for holin function. Using the cross-linker dithiobis(suc-
cinimidyl propionate), S oligomers up to hexamers have been
detected in the cytoplasmic membrane by Western blot anal-
ysis (41). Even without the addition of a cross-linking agent, an
SDS-resistant S dimer band was observed on Western blots
(Fig. 2A, lane 2). Addition of reducing reagents, such as di-
thiothreitol or b-mercaptoethanol, reduced the intensity of this
dimer band but did not completely abolish its appearance (data
not shown). l S has a single cysteine at position 51 which could
be involved in dimer formation through the formation of an
intermolecular disulfide bridge. To test this hypothesis the Cys
codon at position 51 was mutated to Ser in the wild-type S gene
as well as in the S105 and S107 genes (where S105 is SM1L
producing only S105, and S107 is SM3L producing only S107,
with Met3 replaced by a Leu residue [5]). Membrane extracts
were prepared from cells in which S105C51S was expressed. No
dimer band was detected with the cysteineless S variant (Fig.
2A, lane 3), indicating that the SDS-resistant dimer was a
product of disulfide bond formation between Cys51 residues of
two S105 molecules. The presence of NEM during membrane
extraction with Triton X-100 abolished the formation of disul-
fide-bonded dimers, even in the absence of reductant in the
protein sample buffer (Fig. 2B). Thus, the SDS-resistant di-
sulfide-bonded dimers are not formed in the bacterial mem-
brane but during membrane extraction with detergent. The
formation of a disulfide bond is not required for holin function,
since the cysteineless S alleles were fully functional and caused
even earlier lysis than the parental S allele (Fig. 2C).
Specific disulfide bridge formation via single cysteine at
position 51 in the membrane under oxidative conditions. Next
we tested whether disulfide bond formation between two S
molecules could be forced in the bacterial membrane under
oxidative conditions. This would allow the analysis of interac-
tions between transmembrane segments of S. Membranes
from cultures expressing one or two S alleles were subjected
to oxidizing conditions by the addition of CuSO4 and 1-10
phenanthroline. Disulfide bond formation was stopped by the
addition of NEM prior to detergent extraction of the mem-
brane proteins. As shown in Fig. 3, these conditions supported
efficient homodimer formation of S105 and S105t94, the latter
of which carries an oligo-histidine tag insert between residues
94 and 95 (Fig. 1B) and thus displays a reduced mobility during
SDS-PAGE (Fig. 3, lanes 3 and 4). In addition, heterodimers
were formed between S105 and S105t94 (Fig. 3, lane 6). Re-
placement of the cysteine in S105 with a serine prevented
homo- and heterodimer formation (Fig. 3; lanes 5 and 7). Ex-
pression of the same two S alleles S105 and S105t94 in differ-
ent cells failed to produce heterodimers (Fig. 3, lane 8), show-
ing that dimer formation between S molecules occurred indeed
in the membrane environment and not during solubilization or
a subsequent step in sample preparation.
Direct interaction between the lysis protein S105 and the
lysis inhibitor S107 in the bacterial membrane. It has been
proposed that the lysis inhibitor S107 inhibits lysis through
intermolecular interaction with the lysis effector S105 (6). Un-
der oxidative conditions S107 formed disulfide-bonded dimers
in the membrane (Fig. 4, lane 3). The electrophoretic mobility
of S107 homodimers was distinctively faster than the mobility
of the S105t94 homodimers (Fig. 4, lanes 3 to 5), which made
it possible to discriminate between homodimer and hetero-
dimer formation. Indeed, under oxidative conditions efficient
FIG. 2. S monomer and dimer formation in the cytoplasmic membrane. (A) Membrane protein samples were prepared from MC4100(lKnDSR) 1 pS105 (lane 2)
or MC4100(lKnDSR) 1 pS105C51S (lane 3) and analyzed by Western blotting. (B) Membrane protein samples of MC4100(lCmDSR) bearing the plasmids pKB1
(Sam7) (lane 2), pS105 (lane 3), pS105t94 (lane 4), or pS105C51S (lane 5) were prepared in the presence of NEM in the membrane extraction buffer and analyzed by
Western blotting. Molecular weights (mw) of the prestained molecular standards (in thousands) (lane 1) are indicated to the left. S monomer and dimer bands are
indicated by arrows. (C) MC4100(lKnDSR) cells carrying the plasmids pKB110 (S1) (E), pS105 (h), pSC51S (F), or pS105C51S (n ) were induced and monitored for
turbidity.
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heterodimer formation between holin and holin inhibitor was
observed, if the membranes contained both the effector S105t94
and the inhibitor S107 (Fig. 4, lane 6).
The inhibitor function is abolished in the early lysis mu-
tants SC51S and SA52G. The cysteineless S allele SC51S exhibited
an early lysis phenotype (Fig. 2C). The mutant SA52G with a
similar phenotype has been isolated previously by genetic se-
lection (Fig. 5A) (18). The lysis phenotype of both mutants was
distinctive. Expression of wild-type S resulted in retarded lysis,
compared to S105, because the former produces the inhibitor
S107 in addition to the holin effector S105. In contrast, expres-
sion of SC51S or SA52G, which encode both the shorter and
longer forms, resulted in earlier lysis than with the alleles
S105C51S or S105A52G, which produce only the short form of
the protein (Fig. 2C and 5A). This indicated not only that the
S107C51S and S107A52G proteins had lost their inhibitory ca-
pacity but that they had been converted into effectors. A sim-
ilar result has been previously reported for the S107K2E mutant
protein (3).
To examine the lysis phenotype of the mutant S107 proteins
in more detail, we constructed the plasmids pS107, pS107C51S,
and pS107A52G, which each produce only the S107 form. Ex-
pression of the mutant S107 alleles by transactivation in in-
duced lysis-defective lysogens had a more deleterious effect on
cell growth than expression of the parental S107 allele, result-
ing in lysis onset at about 90 to 100 min after induction with
pS107A52G (Fig. 5B). Although S107C51S did not support lysis,
it exhibited more rapid triggering after addition of an energy
poison than the parental S107 allele (Fig. 5C). Furthermore,
expression of these mutant S107 alleles in trans to S105 re-
vealed that these S107 variants exhibit essentially no inhibitory
effect (Fig. 6A). To ensure that this loss of inhibitor capacity
was not due to altered protein synthesis or decreased stability,
the accumulation of S107 and S107C51S proteins was examined
by Western blot analysis and revealed no difference between
the two proteins (Fig. 6B). Therefore, we conclude that the loss
of inhibitory function of the S107C51S allele is not due to
impaired expression or reduced protein stability. Another pos-
sibility is that the loss of the inhibitor function is due to the
inability of the mutant S107 proteins to dimerize with S105.
For S107C51S this cannot be tested with the oxidation method
because of the lack of the Cys residue. However, with A52G,
this method revealed that substantial heterodimer formation
between S107A52G and S105 can be detected (Fig. 6C). Al-
though this technique does not permit quantitative assess-
ment of the capacity for heterodimerization, due to differ-
ential extractability from the oxidized membrane material,
nevertheless we conclude that the severe reduction in the abil-
ity of S107A52G to function as a holin inhibitor does not reflect
a major loss in its ability to interact with S105.
DISCUSSION
The role of the S protein in the l lytic cycle is to terminate
the vegetative phage cycle at a precisely scheduled time by
allowing the fully folded endolysin R access to its substrate, the
peptidoglycan. The structure of the membrane lesion which
permits the transit of R is unknown. In the simplest model, the
S protein, which has three transmembrane domains, would
form an oligomeric hole at least 5 nm in diameter (to allow
passage of the globular R protein [12]) (16, 17, 38). Although
direct evidence for the hole has not yet been obtained, the
available biochemical, genetic, and physiological data support
the concept of a homo-oligomeric lesion in the membrane (39,
41).
The sole cysteine, Cys51, in the l S sequence has been shown
to be located in the core of the second membrane-spanning
domain (17). In this work, it is shown that under oxidative
conditions a disulfide bond between two S molecules can be
formed in the membrane (Fig. 3). Under the oxidative condi-
tions used in these experiments, approximately 50% of the
total S105 protein can be trapped in this covalent dimer form
(Fig. 3). Taken with the finding that the disulfide linkage itself
is not required, as shown by the lytic competence of the C51S
mutant, this suggests that much of the holin pool forms non-
covalent dimers during the period leading to hole formation.
FIG. 3. S dimer formation in the bacterial membrane. Oxidation and sample
preparation for Western blot analysis was performed as described in Materials
and Methods. Samples were prepared from the indicated strains: lane 1,
molecular weight standards; lane 2, MC4100(lCmDSR) 1 pKB1 (Sam7); lane
3, MC4100(lCmDSR) 1 pS105; lane 4, MC4100(lCmDSR) 1 pS105t94; lane 5,
MC4100(lCmDSR) 1 pS105C51S; lane 6, MC4100(lCmS105t94) 1 pS105;
lane 7, MC4100(lCmS105t94) 1 pS105C51S; lane 8, mixed cultures MC4100
(lCmDSR) 1 pS105t94 and MC4100(lCmDSR) 1 pS105; lane 9: mixed cultures
MC4100(lCmDSR) 1 pS105t94 and MC4100(lCmDSR) 1 pS105C51S. Molec-
ular weights of the prestained molecular standards (mw) (in thousands) are
indicated to the left of the panel. S monomer and dimer bands are indicated with
arrows.
FIG. 4. Interaction between the holin S105 and holin inhibitor S107 in the
bacterial membrane. Protein samples were prepared and analyzed by Western
blotting as described in the legend to Fig. 3. Lane 1, molecular weight standards;
lane 2, MC4100(lCmDSR) 1 pKB1 (Sam7); lane 3, MC4100(lCmDSR) 1
pS107; lane 4, MC4100(lCmDSR) 1 pS105t94; lane 5, mixed cultures MC4100
(lCmDSR) 1 pS105t94 and MC4100(lCmDSR) 1 pS107; lane 6, MC4100
(lCmS107) 1 pS105t94. Labeling of the panel is as described in the legend to
Fig. 3.
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Using these oxidative conditions, we were also able to obtain
the first biochemical evidence for a direct interaction between
the lysis effector and the lysis inhibitor (Fig. 4). Although the
effector in this case is the histidine-tagged S105t94 protein,
there is ample evidence that the interaction between it and
S107 is the same as that between S105 and S107. First, the
S105t94 allele is expressed at normal levels and has a normal
lysis time under physiological conditions (31). Moreover, host
lysis by either S105 or S105t94 is retarded equivalently by the
expression of S107 in trans (Fig. 6A and data not shown). It is
worth noting that the proportion of heterodimers formed be-
tween S107 and S105t94, relative to the S107 homodimers, is
apparently higher than that observed with S105 and S105t94,
suggesting that the extra N-terminal Met1 Lys2 sequence con-
fers on the inhibitor form of S a bias towards heterodimer
formation.
It is unknown how the S107 inhibitor acts to block or retard
the action of S105. Recently, Graschopf and Bla¨si (16) re-
ported that fusing a secretory signal sequence to the N termi-
nus of S not only made lysis dependent on cleavage of the
signal sequence but also largely eliminated the functional dif-
ference between the effector and inhibitor forms. This sug-
gested a model in which, after integration of transmembrane
domains 2 and 3 (Fig. 1D) into the bilayer, the N terminus of
S107 with its extra cationic side chain is blocked from pene-
tration by the energized membrane, as reported for leader
petidase Lep and M13 coat protein gpVIII (11, 27). However,
Barenboim et al. (1) have shown that the dual-start motif
functions analogously in the type II holin gene S21, where the
N terminus is almost certainly located in the cytosol. In light of
these findings the longer gene products resulting from dual-
start motifs in class I and II holins may attain inhibitor capacity
by different molecular mechanisms. Regardless of the mecha-
nism, there must be a significant selective advantage in having
FIG. 5. Lysis phenotype of SA52G, S107A52G, and S107C51S. In all panels, lysogens carrying the specified plasmids were induced and monitored for turbidity. (A)
Lysogen, MC4100(lCmDSR); plasmids, pKB110 (S1) (E), pS105 (h), pSA52G (F), or pS105A52G (n ). (B) Lysogen, MC4100(lCmDSR); plasmids, pKB1 (Sam7) (E),
pS107 (h), pS107C51S (F), or pS107A52G (n ). (C) Lysogen, MC4100(lKnDSR); plasmids, pKB1 (Sam7) (E), pS107 (h), or pS107C51S (F). In this experiment the
cultures were divided into two flasks 90 min after induction and 10 mM KCN was added to one flask (dashed lines). The turbidity of the culture was monitored until
lysis was completed or 130 min after induction.
FIG. 6. Expression of S107A52G and S107C51S in trans to S105. (A) The inhibitory effect of the mutant S107 protein was tested in trans to S105. MC4100(lCmS105)
cells carrying the plasmids pKB1 (Sam7) (E), pS107 (h), pS107C51S (F), or pS107A52G (n ) were induced and monitored for turbidity. (B) Expression and stability of
S107 and S107C51S were analyzed by Western blotting as described in Materials and Methods. Samples from the induced cultures were taken 30, 60, or 90 min after
induction. Lane 1, molecular weight standards; lanes 2, 4, and 6, S107; lanes 3, 5, and 7, S107C51S. Time points when samples were taken are indicated below the panel.
Total protein (12.8, 21, or 28 mg) was loaded for the 30, 60, or 90 min time points, respectively. Labeling of the panel is as described in the legend to Fig. 3. (C) Aliquots
(5 ml) of the induced cultures were taken 50 min after induction. Oxidation and sample preparation for Western blot analysis were performed as described in Materials
and Methods. Lane 1, molecular weight standards; lane 2, MC4100(lCmS105t94) 1 pS107A52G; lane 3, MC4100(lCmS105t94) 1 pS107. Labeling of the panel is as
described in the legend to Fig. 3.
VOL. 182, 2000 REQUIREMENTS FOR A HOLIN INHIBITOR 6079
 o
n
 Septem
ber 21, 2018 by guest
http://jb.asm.org/
D
ow
nloaded from
 
an intrinsic inhibitor system, since dual-start motifs have been
identified in a number of other class I and class II holin genes
from phages of both gram-negative and gram-positive bacteria
(37, 39).
The demonstration here of efficient dimerization of holin
proteins within the membrane environment and a direct dimer
interaction between S105 and S107 suggests an operational
basis for this selective advantage. In the scenario depicted in
Fig. 7, it is postulated that the holin dimer is the fundamental
unit of assembly of the holin lesion and that S107 exerts its
inhibitory effect by dimerizing with S105, creating hetero-
dimers which are either nonfunctional or of reduced functional
capacity. Functional, in this case, is defined as counting in the
pathway towards assembly of an oligomeric lesion, which is
drawn in Fig. 7 as a hole of six dimers for illustrative purposes.
This model is supported by the work of Chang et al. (10), which
demonstrated a correlation between lysis timing and the excess
of S105 over S107. Based on the 2:1 ratio of S105 to S107 prior
to the triggering of lysis, about half of the S105 molecules
would be unavailable by virtue of dimerization with S107. If
about 1,000 molecules of S are present per cell at the time of
lysis, then there would be about 500 dimers, of which two-
thirds would be inactive heterodimers if S107 preferentially
complexes with S105. The effect is that the timing of lysis,
reflecting the rate of accumulation of the active S105 ho-
modimers, is delayed because half of the effector is hidden
from participating in the formation of the first lesion. How-
ever, once that first lesion is formed, the membrane potential
would collapse, eliminating the inhibitory capacity of S107 (3,
5). Thus, suddenly all of the previously inactive S105-S107
heterodimers would be triggered into forming the permeabi-
lizing lesions.
Two main advantages are conferred by such a system. First,
very precise adjustment of the timing of hole formation, and
thus the length of the vegetative phase of phage development,
can be achieved by altering the relative proportion of inhibitor
and effector. Wang et al. (36) have shown that there is an
optimal time for lysis for any particular combination of bacte-
rial and phage growth conditions, and clearly the dual-start
motif would constitute an ideal system for evolutionary fine-
tuning to the best lysis time. Moreover, it is possible that there
are physiological conditions that would alter the S105/S107
ratio, either through effects on the translational control of S or
perhaps through selective proteolysis of the inhibitor or effec-
tor forms. Second, the system also confers a saltatory nature to
the lysis phenomenon, because at the instant of triggering
(either when the first hole forms naturally or when an exoge-
nous factor depolarizes the membrane), the amount of func-
tional dimers is trebled, presumably allowing many more per-
meabilizing lesions to form. As has been suggested elsewhere,
it is crucial that the lytic process, once begun, be as rapid and
complete as possible, for the obvious reason that no further
particle assembly occurs once the cell is physiologically dead
because of the permeabilized membrane (6). Thus, the dual-
start motif contributes to keeping the infected cell productive
for as long as is optimal but then minimizing the dwell time in
the lysing corpse of the host.
The data clearly show that the two mutations A52G and
C51S both largely ablate the inhibitory capacity of S107 (Fig.
6A). For the C51S mutation, it is also clear that this loss of
inhibitory function is not due to decreased accumulation in the
membrane (Fig. 6B). Moreover, this loss of inhibitory function
is not due to a general reduction in the ability to participate in
oligomeric interactions, because, at least with A52G, the S107
product not only loses inhibitor function but also gains effector
function (Fig. 5B). Both changes also significantly accelerate
the triggering of lysis in the context of the S105 effector protein
(Fig. 2C and 5A). The simplest interpretation is that the S105-
S107 heterodimers are blocked from participating in the for-
mation of the oligomeric lesion because of a required confor-
mational change that is favored by the A52G and C51S
changes and blocked by the extra N-terminal positive charge
on S107. Experiments to determine whether this involves the
putative externalization of the N-proximal transmembrane do-
main are in progress.
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